Forum Agenda
-
Medicine-Engineering Integration and Innovative Medical Devices
-
China’s Innovation Ecosystem and Models
-
Research Translation and Early-stage Project Incubation Meeting
-
Accelerating Innovation Through External Collaboration Meeting
-
Leveraging China's Innovation to Accelerate Global Drug R&D Meeting
-
USTC Original Innovation Power: Alumni Enterprise Innovation Matrix Meeting
-
Clinical Translation of Medical Research Achievements Meeting
-
Cross-Border Cooperation and China’s New Drug Global Expansion
-
Global Development of Pharma Enterprises and Emerging Market Cooperation
-
Legal Safeguard and Value Empowerment for Globalization of Chinese Pharma Enterprises
-
JunHe LLP Session:New Models of Cross-Border Pharmaceutical Cooperation Session
-
Protheragen Session: Global Biomedical Cross-Border Transactions
-
International Advanced Drug Delivery Systems & Combination Products
Stay tuned
Regulatory Administration of Combination Products in China
Senior Regulatory Expert
Frontiers of Combination Products
Zhen Gu: Assistant to the President, Zhejiang University; Director, State Key Laboratory of Advanced Drug Delivery Systems; Fellow, American Institute for Medical and Biological Engineering, International Academy for Medical and Biological Engineering, and Controlled Release Society
Development of Combination Products Amid the Boom of Large-Volume Subcutaneous Formulations
Liancheng Chen: CTO, ESC MEDICAL
Roundtable 1: Global Development of Combination Products
Lijie Zhang (Moderator): Founder, ESC MEDICAL
Zheng Wang: Co-founder & CEO, Shanghai Bao Pharmaceuticals Co., Ltd.
Quanmin Chen: Vice President, Formulation Development & Clinical Manufacturing, WuXi Biologics
Additional speakers to be announced...
Roundtable 2: R&D Priorities for Manufacturers and Service Providers in Drug-Device Collaboration
Hua Huang (Moderator): CEO, ESC MEDICAL
Yanhua Sun: Director, Peptide Drug Research Department, Qilu Pharmaceutical
Yingchun Li,Director, Biological Products Institute & Macromolecule CMC,R&D Institute, CHIA TAI Tianqing Pharmaceutical Group Co., Ltd.
Additional speakers to be announced...